| 000 | 01256 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250518010958.0 | ||
| 264 | 0 | _c20190729 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1718-7729 | ||
| 024 | 7 |
_a10.3747/co.25.4231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStewart, D A | |
| 245 | 0 | 0 |
_aEvaluation of subcutaneous rituximab administration on Canadian systemic therapy suites. _h[electronic resource] |
| 260 |
_bCurrent oncology (Toronto, Ont.) _c10 2018 |
||
| 300 |
_a300-306 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xadministration & dosage |
| 650 | 0 | 4 | _aCanada |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aLymphoma, Follicular _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 |
_aRituximab _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBoudreault, J S | |
| 700 | 1 | _aMaturi, B | |
| 700 | 1 | _aBoras, D | |
| 700 | 1 | _aFoley, R | |
| 773 | 0 |
_tCurrent oncology (Toronto, Ont.) _gvol. 25 _gno. 5 _gp. 300-306 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3747/co.25.4231 _zAvailable from publisher's website |
| 999 |
_c29079241 _d29079241 |
||